EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 106 filers reported holding EPIZYME INC in Q3 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $37,000 | +5.7% | 25,338 | +81.7% | 0.00% | 0.0% |
| Q4 2021 | $35,000 | -73.1% | 13,948 | +27.6% | 0.00% | -87.5% |
| Q3 2020 | $130,000 | -78.9% | 10,934 | -56.3% | 0.01% | -84.9% |
| Q4 2019 | $615,000 | +3.2% | 25,000 | -47.3% | 0.05% | -1.9% |
| Q2 2019 | $596,000 | +67.4% | 47,474 | +41.3% | 0.05% | +54.3% |
| Q3 2018 | $356,000 | -34.9% | 33,592 | -7.2% | 0.04% | -69.3% |
| Q2 2017 | $547,000 | – | 36,182 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |